Effect of secretin stimulation upon serum immunoreactive trypsin in patients with carcinoma of the pancreas.
The response of serum immunoreactive trypsin (IRT) to the intravenous injection of secretin (75 clinical units) was evaluated in 14 patients with carcinoma of the pancreas and in 20 healthy control patients. A striking increase of serum IRT concentration after secretin, which was much more marked than in those in the control group, was found in patients with localized carcinoma of the pancreas, whereas no increase was observed in those with more diffuse carcinoma.
D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000097:blood / Q000175:diagnosis*; D011863:Radioimmunoassay; D012633:Secretin / Q000008:administration & dosage; D013997:Time Factors; D014357:Trypsin / Q000097:blood*
D012633:Secretin; D014357:Trypsin